Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 244

Archive for 10 novembre 2019

Neustar Partners with Tatango

Posted by fidest press agency su domenica, 10 novembre 2019

Neustar®, Inc., a global information services company and leader in identity resolution, is partnering with Tatango, the market leader in mass text message marketing software, to improve the deliverability of their client’s text messages. Tatango, whose marketing software enables their clients to send mass text messages, powers some of the largest text message marketing campaigns in the United States. Text message deliverability is one of the most critical components to a successful messaging campaign.
Neustar intelligence solutions help companies like Tatango keep up with ever-changing consumer mobile device information, offering real-time, third-party data continuously corroborated against multiple online, offline, and device sources.
Neustar intelligence solutions elevate the effectiveness of inbound and outbound customer support operations, while also minimizing risk, by ensuring companies know exactly who, when and how to contact a consumer, and who is on the other end of inbound interactions. For more information about Neustar, visit https://www.risk.neustar.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Stephens 2019 Nashville Investment Conference

Posted by fidest press agency su domenica, 10 novembre 2019

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that the company is scheduled to participate in the Stephens 2019 Nashville Investment Conference in Nashville, Tennessee. The fireside chat is scheduled to take place on Wednesday, November 13, 2019 at 3:30 p.m. Eastern Time. Matt Korenberg, CFO will attend for Ligand. Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. Ligand’s Captisol® platform technology is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. OmniAb® is a patent-protected transgenic animal platform used in the discovery of fully human mono-and bispecific therapeutic antibodies. Ligand has established multiple alliances, licenses and other business relationships with the world’s leading pharmaceutical companies including Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Headspace Launches Healthy Happy America Campaign

Posted by fidest press agency su domenica, 10 novembre 2019

Headspace, a global leader in mindfulness and meditation, today announced the launch of Healthy Happy America, an initiative to improve the health and happiness of America, one city at a time. The initiative starts in Pittsburgh, Pa. on November 15th, working with the EMBRACE Pittsburgh movement and the CHILL Project to collectively bring everyday mindfulness to the people of Pittsburgh and help the city get happier, stress less and sleep soundly. Healthy Happy America will comprise of a free, two-day event full of activities and spatial experiences held in an interactive series of rooms called The Dot, which will be located in Schenley Plaza. Events will be led by Headspace co-founder Andy Puddicombe and Steelers’ wide receiver JuJu Smith-Schuster.
“Our mission has always been to improve the health and happiness of the world. In a world that feels increasingly stressful for many, we want to inspire people to look after themselves and others, and ensure they have all the tools they need. Starting local and making it feel personal is a big part of that, and we’re very excited to begin this journey with the incredible community and people of Pittsburgh,” said Andy Puddicombe, former Buddhist monk and co-founder of Headspace. Headspace is focusing its social impact efforts on supporting youth initiatives, joining with local schools, the JuJu Foundation, EMBRACE, Carnegie Mellon University and the Allegheny Health Network (AHN) to pilot a mindfulness program based in social and emotional learning (SEL) principles.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Oli Walters Joins Podfront UK

Posted by fidest press agency su domenica, 10 novembre 2019

Podfront UK, an exciting joint venture between two of the biggest podcast players in the world, Wondery and Stitcher, today announced that proven industry leader, Oli Walters will be joining the company as Head of Sales in London, effective immediately. In his new role, Walters will be responsible for driving revenue through sponsorships, host reads and dynamic spot ads engaging with agencies and directly with brands. Podfront UK offers a unique opportunity for UK brands to buy on global hit podcast shows, targeting the UK audience or placing a global campaign.
Walters joins Podfront UK from Audioboom where he successfully managed the UK sales operations and delivered huge revenue increases year on year for the business. He was a key member of the sales team that steered the company to a reported 86% increase on quarterly revenue on Q3 2018. He has nearly 15 years of media experience across broadcast radio and digital audio, and previously worked for the UK’s largest radio groups including Global Radio and Bauer Media.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

AgilVax to Present at the 2019 NYC Oncology Investor Conference

Posted by fidest press agency su domenica, 10 novembre 2019

Conference on November 12, 2019 at 5:30 PM (ET). The conference is being held at the Perkins Coie law firm, 1155 6th Ave, New York City, NY.AgilVax Inc., announced today that Joseph Patti, PhD, President and Chief Executive Officer, will present an overview of the Company and provide an update on its portfolio of targeted antibody-based therapies addressing multiple cancers at the NYC Oncology Investor.
AgilVax has demonstrated in preclinical in vivo models that antibodies to xCT were able to reduce primary tumor formation and the number of lung metastases. xCT overexpression occurs in several cancers leading to metabolic changes that reprograms cells for growth and progression. AgilVax has multiple solutions to target cancer cells that overexpress xCT and when used in combination with existing therapies or alone have the potential to create a durable response in patients suffering from colorectal and other metastatic cancers.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Insulet to Present at Upcoming Investor Conferences

Posted by fidest press agency su domenica, 10 novembre 2019

The 2019 Stephens Nashville Investment Conference in Nashville, TN on Wednesday, November 13, 2019, at 10:30 a.m. (Central Time). The Piper Jaffray 31st Annual Healthcare Conference in New York City, NY on Wednesday, December 4, 2019, at 9:00 a.m. (Eastern Time). Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at two upcoming investor conferences.
Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: http://www.insulet.com and http://www.myomnipod.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Stephens Nashville Investment Conference

Posted by fidest press agency su domenica, 10 novembre 2019

Magellan Health, Inc. (NASDAQ: MGLN) today announced that Jonathan N. Rubin, chief financial officer of Magellan Health, will participate in a fireside chat at the Stephens Nashville Investment Conference on Friday, November 15, 2019, at the Omni Nashville Hotel in Nashville, Tenn. The fireside chat will begin at 8:15 a.m. Central Standard Time. The presentation will be webcast live and can be accessed through the investor relations page at IR.MagellanHealth.com. For those unable to listen to the live broadcast, an audio replay of the fireside chat will be available for 30 days following the presentation on the Company’s investor relations page at IR.MagellanHealth.com.
Magellan Health, Inc., a Fortune 500 company, is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

A Strong Step Forward for the Legal Cannabis Market in Ontario

Posted by fidest press agency su domenica, 10 novembre 2019

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis is pleased to offer its support for the Ontario provincial government’s planned improvements to that province’s retail cannabis program announced yesterday. Changes announced in yesterday’s 2019 Fall Economic Statement include the addition of farmgate sales; private ‘click and collect’ sales; and a pronounced commitment to expanded retail access in the province, which will be limited only by consumer demand.
Organigram, with two corporate offices in Ontario, further applauds the province’s commitment to supporting industry growth in the region, not only for retail and production potential, but for new potential in farmgate-focused ‘canna-tourism’.“These changes not only demonstrate that the province is receptive to consumer and industry feedback but recognize the economic potential of cannabis in Ontario. This improved model will create sustainable jobs for Ontarians across the province and contribute to a robust, thriving national cannabis industry.”

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Allied Wallet Opens New European Office in Bulgaria

Posted by fidest press agency su domenica, 10 novembre 2019

Allied Wallet, a globally leading provider of mainstream online payment processing, is opening an office in Sofia, Bulgaria to support e-commerce growth in Bulgaria and surrounding countries.Allied Wallet has been continuously expanding to support the global need for secure, all-inclusive payment solutions. They recently announced a new office in Beijing, China to support Chinese e-commerce.
Now, they will expand with a new location in Bulgaria to support an annual e-commerce revenue of over $620 million USD in Bulgaria alone. According to export.gov, Bulgaria’s e-commerce revenue is expected to show an annual growth rate of 8.1%, resulting in a market volume of $856 million USD by 2023.“There are over 7 million people in Bulgaria and the majority of them are internet users. We want to not only protect their online transactions, but support new entrepreneurs as they take their businesses online,” said Dr. Andy Khawaja – Founder/CEO of Allied Wallet.Allied Wallet already supports several preferred payment options of the region that many other payment services companies cannot accept, including: Trustly, Easypay, and ePay.bg.Bulgaria’s e-commerce growth can be attributed to the fact that it has one of the fastest average broadband internet connections in the world.
Allied Wallet wants to ensure that all e-commerce transactions are protected as more Bulgarians and surrounding European countries transact online and start online businesses.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

World’s First Cyclic IMS Mass Spectrometer Installed at Aston University

Posted by fidest press agency su domenica, 10 novembre 2019

Aston University and Waters Corporation (NYSE: WAT) announced today the completed installation of the world’s first Waters™ SELECT SERIES™ Cyclic™ IMS (ion mobility spectrometry) mass spectrometer within the University’s School of Health and Life Sciences, where the instrument will support research into the biology of human diseases, the discovery of new therapeutics and advances in biotechnology. Mass spectrometry (MS) is a widely deployed analytical method used by scientists to identify and quantify molecules in a sample and determine their detailed molecular structure. For example, it can be used to more effectively identify disease biomarkers that allow for early detection.Ion mobility spectrometry is a proven technique that separates ions by their size, shape and charge. The SELECT SERIES Cyclic IMS takes ion mobility to a new level, replacing the traditional linear ion mobility region with a novel compact cyclic device. Ions traverse around the cyclic region and with every pass greater ion mobility resolution is achieved. In addition, the advanced technology enables the unique ability to perform ion mobility selection for ion mobility/ion mobility and IMSn experiments.The new instrument will be used by researchers at Aston University and across the Midland Innovation consortium to answer complex biological questions.Andrew Pitt, Professor of Pharmaceutical Chemistry & Chemical Biology, Aston University said: “We are delighted to have this new technology in our lab here at Aston; it will provide us and other researchers in the Midlands with a step change in how we conduct our research.
Founded in 1895 and a University since 1966, Aston is a long established university led by its three main beneficiaries – students, business and the professions, and our region and society. Aston University is located in Birmingham and at the heart of a vibrant city and the campus houses all the university’s academic, social and accommodation facilities for our students. Professor Alec Cameron is the Vice Chancellor & Chief Executive.
Waters Corporation (NYSE: WAT), the world’s leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for more than 60 years. With approximately 7,200 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Posted in Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »

“Neuroendocrine Tumors (NETs) – Market Insights, Epidemiology and Market Forecast-2028”

Posted by fidest press agency su domenica, 10 novembre 2019

Neuroendocrine Tumors (NETs) – Market Insights, Epidemiology and Market Forecast-2028 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of NETs in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan. Neuroendocrine tumors (NETs) are a complex group of tumors that develop predominantly in the digestive or respiratory tracts, but can occur in many areas of the body. These tumors arise from cells called neuroendocrine cells. Like all cancers, NETs develop when the specialized cells undergo changes causing them to divide uncontrollably and grow into an abnormal tissue mass (tumor).
The Neuroendocrine Tumors (NETs) market report gives the thorough understanding of the Neuroendocrine Tumors by including details such as disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends. It also provides treatment algorithms and treatment guidelines for Neuroendocrine Tumors in the US, Europe and Japan.
The Neuroendocrine Tumors (NETs) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken. The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent population, total incident population, total diagnosed prevalent cases of Neuroendocrine Tumors, symptom based classification, diagnosed prevalent cased based on malignancy, site-specific prevalent cases, grade-specific prevalent cases and stage-specific prevalent cases) scenario of Neuroendocrine Tumors (NETs) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2017-2028.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Intelligence to Improve Corporate Hotel Rate Projections

Posted by fidest press agency su domenica, 10 novembre 2019

HRS, the leading Global Hotel Solutions end-to-end technology provider in business travel, today introduced innovative hotel rate projection technology powered by Augmented Artificial Intelligence (AAI). HRS is the first technology company using AAI in support of corporate hotel programs, and one of the few companies using AAI today. Managed travel programs of any size are challenged to ensure the preferred hotel rates they negotiate are competitive. Yet, most of the benchmarks used today are general averages, with other data options often overwhelming or insufficient for final sourcing determinations. As a result, too many companies leave potential savings on the table. HRS, which already sources more global hotel room nights than any travel management company or other outsourced provider, now deploys a higher level of benchmarking and precise rate projection on behalf of its clients. With AAI driving new insights, programs have more leverage in typical hotel negotiations, helping corporations save ten percent or more in their top business destinations. Procurement leaders working with HRS have newfound, more accurate insight as they build 2020 lodging budgets, finalize preferred rates, and integrate those rates into search and book channels.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »